NEW YORK--(BUSINESS WIRE)--Consonance Capital Partners (CCP), a leading U.S. healthcare focused private equity firm, is pleased to announce that Javier Starkand and Sean Breen have been promoted to Partner. Both Javier and Sean joined CCP in 2012 and had previously worked with the Founders prior to CCP.
Stephen McKenna, Managing Partner and Co-Founder of CCP said, “We’re thrilled to recognize these two impressive individuals who have contributed substantially to the firm’s success.” Benjamin Edmands, Managing Partner and Co-Founder added, “Javier and Sean joined our firm during its formation and have grown to take significant responsibility within the firm and provide great leadership. Steve and I and our other Managing Partners and Co-Founders, Nancy-Ann DeParle and Mitchell Blutt, are extremely proud to have them as Partners.”
Javier joined CCP in 2012 and has been involved in our partnerships with KEPRO, Psychiatric Medical Care and Orsini Pharmaceutical Services. Prior to joining CCP, Javier was an investment professional in the healthcare group at Warburg Pincus. Prior to attending business school, he worked as an Associate at JPMorgan Partners before co-founding The Spirus Group. He also worked in the Technology M&A Group at Morgan Stanley. Javier holds an MBA from The Stanford Graduate School of Business. Additionally, he holds a BS in Economics from The Wharton School and a BA in French from the College of Arts & Sciences, both at the University of Pennsylvania.
Sean joined CCP in 2012 and has been involved in our partnerships with Enclara, Bako, Summit Medical Group / CityMD, and Sellers Dorsey. Prior to joining CCP, Sean was an investment professional at CCMP Capital (the successor to JPMorgan Partners) where he focused on growth equity and buyout investments in healthcare, consumer, retail and information services industries. He previously worked in the Global Leveraged Finance Group at Lehman Brothers in the New York office. Sean graduated from Middlebury College with a BA in Economics and History.
About Consonance Capital Partners
Consonance Capital Partners invests in private companies in the lower-to-middle markets of the U.S. healthcare industry with an emphasis on businesses driving efficiency, cost containment and high quality care to patients. Consonance Capital Partners participates in growth equity, leveraged buyout, carve-out, recapitalization and special situation transactions. For more information, please visit www.consonancecapital.com.